Striatal dopamine-2 receptor occupancy in psychotic patients treated with risperidone.

Abstract	Seventeen psychiatric patients (11 with schizophrenia, 5 with other psychotic disorders, and 1 with obsessive-compulsive disorder) were examined by single photon emission computed tomography with 123I-iodobenzamide (IBZM) as tracer. Patients were treated with risperidone in two different dosage groups (3 mg and 8 mg) and haloperidol (10-20 mg) and compared with eight healthy control subjects. There was a statistically significant difference in basal ganglia/frontal cortex ratios of IBZM binding between controls and all treatment groups. A statistically significant difference was also found concerning these ratios and percentage of dopamine D2 receptor occupancy rates between the treatment groups with lowest ratios and highest percentage of D2 receptor occupancy in the group of patients treated with haloperidol, followed by the group treated with 8 mg of risperidone and the group treated with 3 mg of risperidone.
Authors	B Küfferle, T Brücke, A Topitz-Schratzberger, J Tauscher, R Gössler, C Vesely, S Asenbaum, I Podreka, S Kasper
Journal	Psychiatry research (Psychiatry Res) Vol. 68 Issue 1 Pg. 23-30 (Nov 25 1996) ISSN: 0165-1781 [Print] Ireland
PMID	9027930 (Publication Type: Comparative Study, Journal Article)
Chemical References	Antipsychotic Agents Benzamides Dopamine Antagonists Pyrrolidines Receptors, Dopamine D2 3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide Haloperidol Risperidone
Topics	Adolescent Adult Aged Aged, 80 and over Antipsychotic Agents (therapeutic use) Benzamides (pharmacokinetics) Brain Mapping Dopamine Antagonists (pharmacokinetics) Dose-Response Relationship, Drug Female Haloperidol (therapeutic use) Humans Male Middle Aged Obsessive-Compulsive Disorder (diagnostic imaging, drug therapy, psychology) Psychiatric Status Rating Scales Psychotic Disorders (diagnostic imaging, drug therapy, psychology) Pyrrolidines (pharmacokinetics) Receptors, Dopamine D2 (drug effects, physiology) Risperidone (therapeutic use) Schizophrenia (diagnostic imaging, drug therapy) Schizophrenic Psychology Tomography, Emission-Computed, Single-Photon

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!